EUVIMEDEUVIMED entdecken
Open Access

Thymosin alpha 1 restores the immune homeostasis in lymphocytes during Post-Acute sequelae of SARS-CoV-2 infection

Antonella Minutolo, Vita Petrone, Marialaura Fanelli, Christian Maracchioni, Martina Giudice, Elisabetta Teti, Luigi Coppola, Chiara Sorace, Marco Iannetta, Martino Tony Miele, Sergio Bernardini, Antonio Mastino und 7 weitere

International Immunopharmacology · 2023-05 · 118 · 110055

DOI: 10.1016/j.intimp.2023.110055 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2023-05. Verfasst von Antonella Minutolo und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Medicine, University of Rome Tor Vergata, Rome 00133, Italy. Electronic address: antonella.minutolo@uniroma2.it. Hauptthemen laut MEDLINE: COVID-19, Thymosin. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: HORIZON EUROPE Framework Programme, European Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The complex alterations of the immune system and the immune-mediated multiorgan injury plays a key role in host response to SARS-CoV-2 infection and in the pathogenesis of COVID-19, being also associated with adverse outcomes. Thymosin alpha 1 (Tα1) is one of the molecules used in the treatment of COVID-19, as it is known to restore the homeostasis of the immune system during infections and cancer. The use of Tα1 in COVID-19 patients had been widely used in China and in COVID-19 patients, it has been shown to decrease hospitalization rate, especially in those with greater disease severity, and reduce mortality by restoring lymphocytopenia and more specifically, depleted T cells. Persistent dysregulation with depletion of naive B and T cell subpopulations and expansion of memory T cells suggest a chronic stimulation of the immune response in individuals with post-acute sequelae of SARS-CoV-2 infection (PASC). Our data obtained from an ex vivo study, showed that in PASC individuals with a chronically altered immune response, Tα1 improve the restoration of an appropriate response, most evident in those with more severe illness and who need respiratory support during acute phase, and in those with specific systemic and psychiatric symptoms of PASC, confirming Tα1 treatment being more effective in compromised patients. The results obtained, along with promising reports on recent trials on Tα1 administration in patients with COVID-19, offer new insights into intervention also for those patients with long-lasting inflammation with post-infectious symptoms, some of which have a delayed onset.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19ThymosinHumansThymalfasinPost-Acute COVID-19 SyndromeSARS-CoV-2LymphocytesHomeostasis

Stichwörter der Autor:innen

Anti-inflammatory responseImmune regulationPost-acute SARS-CoV-2 symptomsThymosin alpha 1

Substanzen

ThymalfasinThymosin

Autor:innen und Institutionen

  • Department of Experimental Medicine, University of Rome Tor Vergata, Rome 00133, Italy. Electronic address: antonella.minutolo@uniroma2.it.
  • Department of Experimental Medicine, University of Rome Tor Vergata, Rome 00133, Italy.
  • Infectious Diseases Clinic, Tor Vergata Hospital, Rome 00133, Italy.
  • Department of Systems Medicine, University of Rome Tor Vergata, Rome 00133, Italy.
  • Infectious Diseases Clinic, Tor Vergata Hospital, Rome 00133, Italy; Department of Systems Medicine, University of Rome Tor Vergata, Rome 00133, Italy.
  • Institute of Translational Pharmacology, National Research Council, Rome 00133, Italy.

Förderung

  • HORIZON EUROPE Framework Programme
  • European Commission

Zitieren

APA

Minutolo, A., Petrone, V., Fanelli, M., Maracchioni, C., Giudice, M., Teti, E., Coppola, L., Sorace, C., Iannetta, M., Tony Miele, M., Bernardini, S., Mastino, A., Sinibaldi Vallebona, P., Balestrieri, E., Andreoni, M., Sarmati, L., Grelli, S., Garaci, E., & Matteucci, C. (2023). Thymosin alpha 1 restores the immune homeostasis in lymphocytes during Post-Acute sequelae of SARS-CoV-2 infection. International Immunopharmacology, 118, 110055. https://doi.org/10.1016/j.intimp.2023.110055

Vancouver

Minutolo A, Petrone V, Fanelli M, Maracchioni C, Giudice M, Teti E, et al. Thymosin alpha 1 restores the immune homeostasis in lymphocytes during Post-Acute sequelae of SARS-CoV-2 infection. International Immunopharmacology. 2023;118:110055. doi:10.1016/j.intimp.2023.110055

BibTeX
@article{Minutolo2023,
  author = {Minutolo, Antonella and Petrone, Vita and Fanelli, Marialaura and Maracchioni, Christian and Giudice, Martina and Teti, Elisabetta and Coppola, Luigi and Sorace, Chiara and Iannetta, Marco and Tony Miele, Martino and Bernardini, Sergio and Mastino, Antonio and Sinibaldi Vallebona, Paola and Balestrieri, Emanuela and Andreoni, Massimo and Sarmati, Loredana and Grelli, Sandro and Garaci, Enrico and Matteucci, Claudia},
  title = {Thymosin alpha 1 restores the immune homeostasis in lymphocytes during Post-Acute sequelae of SARS-CoV-2 infection},
  journal = {International Immunopharmacology},
  year = {2023},
  volume = {118},
  pages = {110055},
  doi = {10.1016/j.intimp.2023.110055}
}
Kostenlos starten →